Global Markets

Ipsen (IPN FP) CEO says that they are considering potential US manufacturing investment for plant to make neuroscience drugs

StockNow breaking-news AI analysis

Ipsen considers US neuroscience manufacturing amid broader industry capital investments expanding domestic American pharmaceutical production capabilities.

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more